Miguel Yus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Miguel Yus has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Jordi A. Matias-Guiu
Hospital Clinico San Carlos
9 shared publications - Alberto Marcos
Neurology Department, Hospital Clínico San Carlos and Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid Spain
4 shared publications Cristina Delgado-Alonso
Department of Neurology, Hospital Universitario Clínico San Carlos. Health Research Institute “San Carlos” (IdISCC). Universidad Complutense de Madrid, Madrid, Spain
4 shared publications- Jorge Matías-Guiu
Department of Neurology, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Universidad Complutense de Madrid, Hospital Clinico San Carlos, Madrid, Spain
4 shared publications - Manuela Jorquera
Servicio de Radiología, Hospital Clínico San Carlos, Madrid, España
4 shared publications - María Díez-Cirarda
Department of Neurology, Hospital Clínico San Carlos, San Carlos Health Research Institute (IdISSC), Universidad Complutense de Madrid , Madrid 28040
4 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 15 January 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (7) , 2821-2830
Choroid plexus volume is enlarged in long COVID and associated with cognitive and brain changes
Patients with post-COVID condition (PCC) present with diverse symptoms which persist at long-term after SARS-CoV-2 infection. Among these symptoms, cognitive impairment is one of the most prevalent and has been related to brain structural and functional changes. The underlying mechanisms of these cognitive and brain alterations remain elusive but neuroinflammation and immune mechanisms have been majorly considered. In this sense, the choroid plexus (ChP) volume has been proposed as a marker of neuroinflammation in immune-mediated conditions and the ChP epithelium has been found particularly susceptible to the effects of SARS-CoV-2. The objective was to investigate the ChP in PCC and evaluate its relationships with cognition, brain, and immunological alterations. One-hundred and twenty-nine patients with PCC after a mean of 14.79 ± 7.17 months of evolution since the infection and 36 healthy controls were recruited. Participants underwent a neuropsychological, and neuroimaging assessment and immunological markers evaluation. Results revealed ChP volume enlargement in PCC compared to healthy controls. The ChP enlargement was associated with cognitive dysfunction, grey matter volume reduction in frontal and subcortical areas, white matter integrity and diffusivity changes and functional connectivity changes. These ChP changes were also related to intermediate monocytes levels. Findings suggest that the ChP integrity may play a relevant role in the pathophysiology of cognitive deficits and the observed brain changes in PCC. The previously documented function of the ChP in maintaining brain homeostasis and regulating the entry of immune cells into the brain supports the presence of neuroinflammatory mechanisms in this disorder.
- 15 January 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (7) , 2821-2830
Top Cited PapersOpen AccessChoroid plexus volume is enlarged in long COVID and associated with cognitive and brain changes
Patients with post-COVID condition (PCC) present with diverse symptoms which persist at long-term after SARS-CoV-2 infection. Among these symptoms, cognitive impairment is one of the most prevalent and has been related to brain structural and functional changes. The underlying mechanisms of these cognitive and brain alterations remain elusive but neuroinflammation and immune mechanisms have been majorly considered. In this sense, the choroid plexus (ChP) volume has been proposed as a marker of neuroinflammation in immune-mediated conditions and the ChP epithelium has been found particularly susceptible to the effects of SARS-CoV-2. The objective was to investigate the ChP in PCC and evaluate its relationships with cognition, brain, and immunological alterations. One-hundred and twenty-nine patients with PCC after a mean of 14.79 ± 7.17 months of evolution since the infection and 36 healthy controls were recruited. Participants underwent a neuropsychological, and neuroimaging assessment and immunological markers evaluation. Results revealed ChP volume enlargement in PCC compared to healthy controls. The ChP enlargement was associated with cognitive dysfunction, grey matter volume reduction in frontal and subcortical areas, white matter integrity and diffusivity changes and functional connectivity changes. These ChP changes were also related to intermediate monocytes levels. Findings suggest that the ChP integrity may play a relevant role in the pathophysiology of cognitive deficits and the observed brain changes in PCC. The previously documented function of the ChP in maintaining brain homeostasis and regulating the entry of immune cells into the brain supports the presence of neuroinflammatory mechanisms in this disorder.
- Open Access
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S4)
Electrophysiological signatures of memory depletion in mild cognitive impairment
Background: MCI diagnosis does not necessarily imply the development of dementia. For this reason, characterizing the MCI profile is fundamental to the early identification of electrophysiological markers associated with a higher risk of developing Alzheimer’s Disease (AD). Longitudinal studies demonstrated that the delay recall measure is a good predictor of conversion and is one of the most common manifestations of the preclinical stage. This study has for purpose compared the power spectrum in the resting‐state of MCI and their relationship with neuropsychological and structural measures.Method: We compared the power spectrum in resting‐state eyes‐closed magnetoencephalographic of 93 MCI participants (aged from 64 to 87) recruited from the Hospital Universitario San Carlos (Madrid, Spain). According to their memory performance in delay recall, the sample was split into (i) ‘moderate’ MCI (n = 52) group and (ii) ‘severe’ MCI (n = 41) group. The groups did not differ in age or years of education.Results: The severe MCI patients showed higher theta power than patients with moderate MCI were significant differences between both. Also, moderate MCI correlated significantly with years of education (rho = ‐0.31, p < 0.02) and TMT A time (rho = 0.40, p < 0.004). In the Severe MCI group, the theta power showed significant correlation with MMSE (rho = ‐0.43, p < 0.001) and total hippocampus (rho = 0.41, p < 0.001).Conclusion: Loss of delay recall performance seems to be associated with electrophysiological alterations that can be used as non‐invasive markers of AD progression.
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S4)
Open AccessElectrophysiological signatures of memory depletion in mild cognitive impairment
Background: MCI diagnosis does not necessarily imply the development of dementia. For this reason, characterizing the MCI profile is fundamental to the early identification of electrophysiological markers associated with a higher risk of developing Alzheimer’s Disease (AD). Longitudinal studies demonstrated that the delay recall measure is a good predictor of conversion and is one of the most common manifestations of the preclinical stage. This study has for purpose compared the power spectrum in the resting‐state of MCI and their relationship with neuropsychological and structural measures.Method: We compared the power spectrum in resting‐state eyes‐closed magnetoencephalographic of 93 MCI participants (aged from 64 to 87) recruited from the Hospital Universitario San Carlos (Madrid, Spain). According to their memory performance in delay recall, the sample was split into (i) ‘moderate’ MCI (n = 52) group and (ii) ‘severe’ MCI (n = 41) group. The groups did not differ in age or years of education.Results: The severe MCI patients showed higher theta power than patients with moderate MCI were significant differences between both. Also, moderate MCI correlated significantly with years of education (rho = ‐0.31, p < 0.02) and TMT A time (rho = 0.40, p < 0.004). In the Severe MCI group, the theta power showed significant correlation with MMSE (rho = ‐0.43, p < 0.001) and total hippocampus (rho = 0.41, p < 0.001).Conclusion: Loss of delay recall performance seems to be associated with electrophysiological alterations that can be used as non‐invasive markers of AD progression.
- 10 December 2022
- Published by Elsevier in Psychiatry Research
- Vol. 319, 115006
Development of criteria for cognitive dysfunction in post-COVID syndrome: the IC-CoDi-COVID approach
- 10 December 2022
- Published by Elsevier in Psychiatry Research
- Vol. 319, 115006
Development of criteria for cognitive dysfunction in post-COVID syndrome: the IC-CoDi-COVID approach
- Open Access
- 7 November 2022
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 44 (2) , 113-125
Coronary microvascular dysfunction is associated with impaired cognitive function: the Cerebral-Coronary Connection study (C3 study)
It remains unknown whether the presence of coronary microcirculatory dysfunction (CMD) correlates with its equivalent condition in the brain, cerebral small vessel disease (CSVD). The cerebral-coronary connection (C3), a prospective blinded study, investigated the prevalence of CMD in patients with coronary artery disease (CAD) and its association with CSVD and cognitive function. Patients with documented CAD fulfilling inclusion criteria underwent physiological assessment of epicardial vessels and the microcirculation using intracoronary pressure and Doppler. Coronary microcirculation-related indices included coronary flow reserve (CFR) and hyperaemic microvascular resistance. Brain magnetic resonance imaging, transcranial Doppler (TCD), and neurocognitive examination were performed. Overall, 67 patients were included in the study (mean age 66 years, 73% female). Patients with abnormal CFR (P = 0.044). After statistical adjustment, low CFR was associated with lower grey matter volume (P = 0.024) and with parameters of white-matter microstructural damage in diffusion-tensor imaging (lower fractional anisotropy and higher mean diffusivity, P = 0.029 and P = 0.032, respectively). Low CFR was associated with higher resistive (P = 0.027) and pulsatility (P = 0.043) values on TCD, and worse neurocognitive test scores (lower mini mental state examination, P = 0.025, and slower Trail Making Test A, P = 0.034). Coronary microcirculatory dysfunction is frequent in patients with CAD and correlates with CSVD, abnormal cerebral flow haemodynamics, and significant cognitive impairment. These findings support the hypothesis that microvascular dysfunction in the heart and the brain are part of a single pathological process affecting microcirculation in patients with CAD. ClinicalTrials.gov NCT04131075. CFR, coronary flow reserve; FFR, fractional flow reserve; MMSE, mini mental state examination; ACE-III, Addenbrooke’s Cognitive Examination (attention domain); TMT-A, Trail Making Test A; MRI, magnetic resonance imaging; WMH, white-matter hyperintensity; FA, fractional anisotropy; MD, mean diffusivity; GM, grey matter.
- 7 November 2022
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 44 (2) , 113-125
Open AccessCoronary microvascular dysfunction is associated with impaired cognitive function: the Cerebral-Coronary Connection study (C3 study)
It remains unknown whether the presence of coronary microcirculatory dysfunction (CMD) correlates with its equivalent condition in the brain, cerebral small vessel disease (CSVD). The cerebral-coronary connection (C3), a prospective blinded study, investigated the prevalence of CMD in patients with coronary artery disease (CAD) and its association with CSVD and cognitive function. Patients with documented CAD fulfilling inclusion criteria underwent physiological assessment of epicardial vessels and the microcirculation using intracoronary pressure and Doppler. Coronary microcirculation-related indices included coronary flow reserve (CFR) and hyperaemic microvascular resistance. Brain magnetic resonance imaging, transcranial Doppler (TCD), and neurocognitive examination were performed. Overall, 67 patients were included in the study (mean age 66 years, 73% female). Patients with abnormal CFR (P = 0.044). After statistical adjustment, low CFR was associated with lower grey matter volume (P = 0.024) and with parameters of white-matter microstructural damage in diffusion-tensor imaging (lower fractional anisotropy and higher mean diffusivity, P = 0.029 and P = 0.032, respectively). Low CFR was associated with higher resistive (P = 0.027) and pulsatility (P = 0.043) values on TCD, and worse neurocognitive test scores (lower mini mental state examination, P = 0.025, and slower Trail Making Test A, P = 0.034). Coronary microcirculatory dysfunction is frequent in patients with CAD and correlates with CSVD, abnormal cerebral flow haemodynamics, and significant cognitive impairment. These findings support the hypothesis that microvascular dysfunction in the heart and the brain are part of a single pathological process affecting microcirculation in patients with CAD. ClinicalTrials.gov NCT04131075. CFR, coronary flow reserve; FFR, fractional flow reserve; MMSE, mini mental state examination; ACE-III, Addenbrooke’s Cognitive Examination (attention domain); TMT-A, Trail Making Test A; MRI, magnetic resonance imaging; WMH, white-matter hyperintensity; FA, fractional anisotropy; MD, mean diffusivity; GM, grey matter.
- Top Cited Papers
- 26 October 2022
- Published by Oxford University Press (OUP) in Brain
- Vol. 146 (5) , 2142-2152
Multimodal neuroimaging in post-COVID syndrome and correlation with cognition
Brain changes have been reported in the first weeks after SARS-CoV-2 infection. However, limited literature exists about brain alterations in post-COVID syndrome, a condition increasingly associated with cognitive impairment. The present study aimed to evaluate brain functional and structural alterations in patients with post-COVID syndrome, and assess whether these brain alterations were related to cognitive dysfunction. Eighty-six patients with post-COVID syndrome and 36 healthy controls were recruited and underwent neuroimaging acquisition and a comprehensive neuropsychological assessment. Cognitive and neuroimaging examinations were performed 11 months after the first symptoms of SARS-CoV-2. Whole-brain functional connectivity analysis was performed. Voxel-based morphometry was performed to evaluate grey matter volume, and diffusion tensor imaging was carried out to analyse white-matter alterations. Correlations between cognition and brain changes were conducted and Bonferroni corrected. Post-COVID syndrome patients presented with functional connectivity changes, characterized by hypoconnectivity between left and right parahippocampal areas, and between bilateral orbitofrontal and cerebellar areas compared to controls. These alterations were accompanied by reduced grey matter volume in cortical, limbic and cerebellar areas, and alterations in white matter axial and mean diffusivity. Grey matter volume loss showed significant associations with cognitive dysfunction. These cognitive and brain alterations were more pronounced in hospitalized patients compared to non-hospitalized patients. No associations with vaccination status were found. The present study shows persistent structural and functional brain abnormalities 11 months after the acute infection. These changes are associated with cognitive dysfunction and contribute to a better understanding of the pathophysiology of the post-COVID syndrome.
- 26 October 2022
- Published by Oxford University Press (OUP) in Brain
- Vol. 146 (5) , 2142-2152
Top Cited PapersMultimodal neuroimaging in post-COVID syndrome and correlation with cognition
Brain changes have been reported in the first weeks after SARS-CoV-2 infection. However, limited literature exists about brain alterations in post-COVID syndrome, a condition increasingly associated with cognitive impairment. The present study aimed to evaluate brain functional and structural alterations in patients with post-COVID syndrome, and assess whether these brain alterations were related to cognitive dysfunction. Eighty-six patients with post-COVID syndrome and 36 healthy controls were recruited and underwent neuroimaging acquisition and a comprehensive neuropsychological assessment. Cognitive and neuroimaging examinations were performed 11 months after the first symptoms of SARS-CoV-2. Whole-brain functional connectivity analysis was performed. Voxel-based morphometry was performed to evaluate grey matter volume, and diffusion tensor imaging was carried out to analyse white-matter alterations. Correlations between cognition and brain changes were conducted and Bonferroni corrected. Post-COVID syndrome patients presented with functional connectivity changes, characterized by hypoconnectivity between left and right parahippocampal areas, and between bilateral orbitofrontal and cerebellar areas compared to controls. These alterations were accompanied by reduced grey matter volume in cortical, limbic and cerebellar areas, and alterations in white matter axial and mean diffusivity. Grey matter volume loss showed significant associations with cognitive dysfunction. These cognitive and brain alterations were more pronounced in hospitalized patients compared to non-hospitalized patients. No associations with vaccination status were found. The present study shows persistent structural and functional brain abnormalities 11 months after the acute infection. These changes are associated with cognitive dysfunction and contribute to a better understanding of the pathophysiology of the post-COVID syndrome.
- Open Access
- 4 July 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (13) , 3886
Neuropsychological Predictors of Fatigue in Post-COVID Syndrome
Fatigue is one of the most disabling symptoms in several neurological disorders and has an important cognitive component. However, the relationship between self-reported cognitive fatigue and objective cognitive assessment results remains elusive. Patients with post-COVID syndrome often report fatigue and cognitive issues several months after the acute infection. We aimed to develop predictive models of fatigue using neuropsychological assessments to evaluate the relationship between cognitive fatigue and objective neuropsychological assessment results. We conducted a cross-sectional study of 113 patients with post-COVID syndrome, assessing them with the Modified Fatigue Impact Scale (MFIS) and a comprehensive neuropsychological battery including standardized and computerized cognitive tests. Several machine learning algorithms were developed to predict MFIS scores (total score and cognitive fatigue score) based on neuropsychological test scores. MFIS showed moderate correlations only with the Stroop Color–Word Interference Test. Classification models obtained modest F1-scores for classification between fatigue and non-fatigued or between 3 or 4 degrees of fatigue severity. Regression models to estimate the MFIS score did not achieve adequate R2 metrics. Our study did not find reliable neuropsychological predictors of cognitive fatigue in the post-COVID syndrome. This has important implications for the interpretation of fatigue and cognitive assessment. Specifically, MFIS cognitive domain could not properly capture actual cognitive fatigue. In addition, our findings suggest different pathophysiological mechanisms of fatigue and cognitive dysfunction in post-COVID syndrome.
- 4 July 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (13) , 3886
Open AccessNeuropsychological Predictors of Fatigue in Post-COVID Syndrome
Fatigue is one of the most disabling symptoms in several neurological disorders and has an important cognitive component. However, the relationship between self-reported cognitive fatigue and objective cognitive assessment results remains elusive. Patients with post-COVID syndrome often report fatigue and cognitive issues several months after the acute infection. We aimed to develop predictive models of fatigue using neuropsychological assessments to evaluate the relationship between cognitive fatigue and objective neuropsychological assessment results. We conducted a cross-sectional study of 113 patients with post-COVID syndrome, assessing them with the Modified Fatigue Impact Scale (MFIS) and a comprehensive neuropsychological battery including standardized and computerized cognitive tests. Several machine learning algorithms were developed to predict MFIS scores (total score and cognitive fatigue score) based on neuropsychological test scores. MFIS showed moderate correlations only with the Stroop Color–Word Interference Test. Classification models obtained modest F1-scores for classification between fatigue and non-fatigued or between 3 or 4 degrees of fatigue severity. Regression models to estimate the MFIS score did not achieve adequate R2 metrics. Our study did not find reliable neuropsychological predictors of cognitive fatigue in the post-COVID syndrome. This has important implications for the interpretation of fatigue and cognitive assessment. Specifically, MFIS cognitive domain could not properly capture actual cognitive fatigue. In addition, our findings suggest different pathophysiological mechanisms of fatigue and cognitive dysfunction in post-COVID syndrome.
- Top Cited Papers
- 24 March 2022
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 150, 40-46
Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study
- 24 March 2022
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 150, 40-46
Top Cited PapersCognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study
- Open Access
- 14 February 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (2) , 265
Examining Association of Personality Characteristics and Neuropsychiatric Symptoms in Post-COVID Syndrome
Background: We aimed to evaluate personality traits in patients with post-COVID syndrome, as well as the association with neuropsychiatric symptoms present in this disorder. Methods: The Big Five Structure Inventory was administered to 93 consecutive patients with a diagnosis of post-COVID syndrome as defined by the WHO and to demographically matched controls. We also performed a comprehensive evaluation of depression, anxiety, fatigue, sleep quality, cognitive function, and olfactory function. Results: Patients with post-COVID syndrome scored lower for emotional stability, equanimity, positive mood, and self-control. Extraversion, emotional stability, and openness correlated negatively with anxiety and depression levels. Conscientiousness correlated negatively with anxiety. No statistically significant correlations were observed between personality traits and cognitive function, sleep quality, olfactory function, or fatigue. Personality scores explained 36.3% and 41% of the variance in scores on the anxiety and depression scales, respectively. Two personality profiles with lower levels of emotional stability were associated with depression and anxiety. Conclusions: Our study shows higher levels of neuroticism in patients with post-COVID syndrome. Personality traits were predictive of the presence of depression and anxiety, but not cognitive function, sleep quality, or fatigue, in the context of post-COVID syndrome. These findings may have implications for the detection of patients at risk of depression and anxiety in post-COVID syndrome, and for the development of preventive and therapeutic interventions.
- 14 February 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (2) , 265
Open AccessExamining Association of Personality Characteristics and Neuropsychiatric Symptoms in Post-COVID Syndrome
Background: We aimed to evaluate personality traits in patients with post-COVID syndrome, as well as the association with neuropsychiatric symptoms present in this disorder. Methods: The Big Five Structure Inventory was administered to 93 consecutive patients with a diagnosis of post-COVID syndrome as defined by the WHO and to demographically matched controls. We also performed a comprehensive evaluation of depression, anxiety, fatigue, sleep quality, cognitive function, and olfactory function. Results: Patients with post-COVID syndrome scored lower for emotional stability, equanimity, positive mood, and self-control. Extraversion, emotional stability, and openness correlated negatively with anxiety and depression levels. Conscientiousness correlated negatively with anxiety. No statistically significant correlations were observed between personality traits and cognitive function, sleep quality, olfactory function, or fatigue. Personality scores explained 36.3% and 41% of the variance in scores on the anxiety and depression scales, respectively. Two personality profiles with lower levels of emotional stability were associated with depression and anxiety. Conclusions: Our study shows higher levels of neuroticism in patients with post-COVID syndrome. Personality traits were predictive of the presence of depression and anxiety, but not cognitive function, sleep quality, or fatigue, in the context of post-COVID syndrome. These findings may have implications for the detection of patients at risk of depression and anxiety in post-COVID syndrome, and for the development of preventive and therapeutic interventions.
- Open Access
- 20 December 2018
- Published by Springer Nature in BMC Neurology
- Vol. 18 (1) , 1-8
Structural MRI correlates of PASAT performance in multiple sclerosis
The Paced Auditory Serial Addition Test (PASAT) is a useful cognitive test in patients with multiple sclerosis (MS), assessing sustained attention and information processing speed. However, the neural underpinnings of performance in the test are controversial. We aimed to study the neural basis of PASAT performance by using structural magnetic resonance imaging (MRI) in a series of 242 patients with MS. PASAT (3-s) was administered together with a comprehensive neuropsychological battery. Global brain volumes and total T2-weighted lesion volumes were estimated. Voxel-based morphometry and lesion symptom mapping analyses were performed. Mean PASAT score was 42.98 ± 10.44; results indicated impairment in 75 cases (31.0%). PASAT score was correlated with several clusters involving the following regions: bilateral precuneus and posterior cingulate, bilateral caudate and putamen, and bilateral cerebellum. Voxel-based lesion symptom mapping showed no significant clusters. Region of interest–based analysis restricted to white matter regions revealed a correlation with the left cingulum, corpus callosum, bilateral corticospinal tracts, and right arcuate fasciculus. Correlations between PASAT scores and global volumes were weak. PASAT score was associated with regional volumes of the posterior cingulate/precuneus and several subcortical structures, specifically the caudate, putamen, and cerebellum. This emphasises the role of both cortical and subcortical structures in cognitive functioning and information processing speed in patients with MS.
- 20 December 2018
- Published by Springer Nature in BMC Neurology
- Vol. 18 (1) , 1-8
Open AccessStructural MRI correlates of PASAT performance in multiple sclerosis
The Paced Auditory Serial Addition Test (PASAT) is a useful cognitive test in patients with multiple sclerosis (MS), assessing sustained attention and information processing speed. However, the neural underpinnings of performance in the test are controversial. We aimed to study the neural basis of PASAT performance by using structural magnetic resonance imaging (MRI) in a series of 242 patients with MS. PASAT (3-s) was administered together with a comprehensive neuropsychological battery. Global brain volumes and total T2-weighted lesion volumes were estimated. Voxel-based morphometry and lesion symptom mapping analyses were performed. Mean PASAT score was 42.98 ± 10.44; results indicated impairment in 75 cases (31.0%). PASAT score was correlated with several clusters involving the following regions: bilateral precuneus and posterior cingulate, bilateral caudate and putamen, and bilateral cerebellum. Voxel-based lesion symptom mapping showed no significant clusters. Region of interest–based analysis restricted to white matter regions revealed a correlation with the left cingulum, corpus callosum, bilateral corticospinal tracts, and right arcuate fasciculus. Correlations between PASAT scores and global volumes were weak. PASAT score was associated with regional volumes of the posterior cingulate/precuneus and several subcortical structures, specifically the caudate, putamen, and cerebellum. This emphasises the role of both cortical and subcortical structures in cognitive functioning and information processing speed in patients with MS.